NEOIMMUNETECH, INC.

Insiders NeoImmuneTech, Inc.

Equities

A950220

KR8840140006

End-of-day quote Korea S.E. Other stock markets 03:30:00 13/06/2024 am IST			5-day change	1st Jan Change
1,601 ^KRW	-1.05%		-4.87%	-20.94%

03/06	NeoImmuneTech's New Data at ASCO 2024 Highlights Enhanced Benefits of Combining NT-I7 with Checkpoint Inhibitors in Immuno-Oncology	CI
02/04	NeoImmuneTech, Inc. Announces Chief Executive Officer Changes	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeoImmuneTech, Inc. Announces Chief Executive Officer Changes	02/04	CI
NeoImmuneTech, Inc. Appoints Luke Oh as President	15/01	CI
Neoimmunetech, Inc. Appoints Benny J. Chen and Su-Hyung Park to Its Scientific Advisory Board	26/23/26	CI
NeoImmuneTech, Inc. Appoints New Members to its Scientific Advisory Board	08/22/08	CI
NeoImmuneTech, Inc. Appoints Jean Fan, M.D., as Chief Clinical Officer	25/21/25	CI
NeoImmuneTech, Inc. Appoints Byung Ha Lee, Ph.D., as Chief Scientific Officer	01/21/01	CI
NeoImmuneTech, Inc. Appoints Gene Namgoong as Chief Operating Officer	30/20/30	CI
NeoImmuneTech Announces Scientific Advisory Board Appointments	22/19/22	CI
NeoImmuneTech Announces Formation of Scientific Advisory Board	13/19/13	CI
NeoImmuneTech, Inc. Appoints Dr. Samuel Zhang as Chief Business Officer	03/19/03	CI
NeoImmuneTech, Inc. Appoints NgocDiep Le as Chief Medical Officer	29/18/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer